Hoffman David Andrew - Insider Non-Derivative Transactions at First Wave BioPharma, Inc. (FWBI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 3, 2023, Hoffman David Andrew's relationship to First Wave BioPharma, Inc. (FWBI) is Director, and currently has 90,778 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FWBI insiders.
Data Source: SEC.
Hoffman David Andrew - Insider Non-Derivative Transactions at FWBI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 4, 2023 | Acquisition -- (Common Stock) | 84745 | 0 | 90778 |